Although IGFBP-3 may utilize multiple mechanisms for its anti-tumor actions, current findings suggest that the IGFBP-3/IGFBP-3R axis may constitute a novel anti-tumor/anti-metastatic signaling pathway and a novel potential therapeutic target in cancer. The gene discussed is LRP1; the disease is neoplasm.